Terms: = Gastric cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
427 results:
1. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/akt pathway.
Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
[TBL] [Abstract] [Full Text] [Related]
2. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
Zhong Q; Hong W; Xiong L
Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
[TBL] [Abstract] [Full Text] [Related]
3. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via akt-mTOR-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract] [Full Text] [Related]
4. PXMP4 promotes gastric cancer cell epithelial-mesenchymal transition via the PI3K/akt signaling pathway.
Li W; Dong X; Wan Z; Wang W; Zhang J; Mi Y; Li R; Xu Z; Wang B; Li N; He G
Mol Biol Rep; 2024 Feb; 51(1):350. PubMed ID: 38401002
[TBL] [Abstract] [Full Text] [Related]
5. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-akt-mTOR pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
6. ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the akt/FBLN2 axis.
Shen K; Xia W; Wang K; Li J; Xu W; Liu H; Yang K; Zhu J; Wang J; Xi Q; Shi T; Li R
J Cell Mol Med; 2024 Feb; 28(4):e18113. PubMed ID: 38332530
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study.
Zheng HL; Wei LH; Xu BB; Zheng HH; Xue Z; Chen QY; Xie JW; Zheng CH; Huang CM; Lin JX; Li P
Eur J Surg Oncol; 2024 Mar; 50(3):108004. PubMed ID: 38330540
[TBL] [Abstract] [Full Text] [Related]
8. [High expression of CPNE3 correlates with poor long-term prognosis of gastric cancer by inhibiting cell apoptosis
Duan T; Zhang Z; Shi J; Xiao L; Yang J; Yin L; Zhang X; Geng Z; Lu G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):129-137. PubMed ID: 38293984
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
10. MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/akt signaling pathway activation.
Yu S; Chen C; Chen M; Liang J; Jiang K; Lou B; Lu J; Zhu X; Zhou D
J Exp Clin Cancer Res; 2024 Jan; 43(1):32. PubMed ID: 38268030
[TBL] [Abstract] [Full Text] [Related]
11. Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models.
Puliga E; De Bellis C; Vietti Michelina S; Capeloa T; Migliore C; Orrù C; Baiocchi GL; De Manzoni G; Pietrantonio F; Reddavid R; Fumagalli Romario U; Ambrogio C; Corso S; Giordano S
Gastric Cancer; 2024 May; 27(3):473-483. PubMed ID: 38261067
[TBL] [Abstract] [Full Text] [Related]
12. racGAP1 drives proliferation, migration and invasion and suppresses autophagy of gastric cancer cells via inhibiting SIRT1/Mfn2.
Yan T; Lu G; Shang R; Hu J; Zhu C; Jin L
Physiol Int; 2024 Mar; 111(1):35-46. PubMed ID: 38261006
[TBL] [Abstract] [Full Text] [Related]
13. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
14. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the PI3K/akt/mTOR signaling pathway.
Han A; Liu T; Du P; Wang M; Liu J; Chen L
Mol Carcinog; 2024 Apr; 63(4):688-700. PubMed ID: 38224261
[TBL] [Abstract] [Full Text] [Related]
15. Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
[TBL] [Abstract] [Full Text] [Related]
16. The role of α7-nAChR-mediated PI3K/akt pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
17. Cross-talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis.
Ren C; Yang Z; Xu E; Kang X; Wang X; Sun Q; Wang C; Zhang L; Miao J; Luo B; Chen K; Liu S; Shen X; Lu X; Yin K; Wang M; Xia X; Guan W
Cancer Sci; 2024 Feb; 115(2):369-384. PubMed ID: 38050654
[TBL] [Abstract] [Full Text] [Related]
18. Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/akt/mTOR pathway in gastric cancer.
Jin Y; Xia Y; Du H; Xiang T; Lan B; Wei S; Li H; Huang H
Biochem Biophys Res Commun; 2023 Dec; 689():149188. PubMed ID: 37976838
[TBL] [Abstract] [Full Text] [Related]
19. [High expression of RAB7A is associated with poor prognosis of gastric cancer by promoting tumor invasion].
Zhang M; Liu S; Zhang N; Zhang W; Xia Y; Song X; Zhang X; Zuo L; Li J; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1734-1743. PubMed ID: 37933649
[TBL] [Abstract] [Full Text] [Related]
20. Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.
Li A; Li Y; Li Y; Zhang M; Zhang H; Chen F
PeerJ; 2023; 11():e16243. PubMed ID: 37868053
[TBL] [Abstract] [Full Text] [Related]
[Next]